These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 19768245)

  • 1. [Hyperhomocysteinemia and cardiometabolic risk].
    Vannucchi H; Melo SS
    Arq Bras Endocrinol Metabol; 2009 Jul; 53(5):540-9. PubMed ID: 19768245
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DACH-LIGA homocystein (german, austrian and swiss homocysteine society): consensus paper on the rational clinical use of homocysteine, folic acid and B-vitamins in cardiovascular and thrombotic diseases: guidelines and recommendations.
    Stanger O; Herrmann W; Pietrzik K; Fowler B; Geisel J; Dierkes J; Weger M;
    Clin Chem Lab Med; 2003 Nov; 41(11):1392-403. PubMed ID: 14656016
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Hyperhomocysteinemia in pediatric age and nutritional aspects of folates: an early cardiovascular risk factor].
    Caramia G; Belardinelli R
    Monaldi Arch Chest Dis; 2006 Dec; 66(4):275-85. PubMed ID: 17312847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Homocysteine lowering and cardiovascular disease risk: lost in translation.
    Marcus J; Sarnak MJ; Menon V
    Can J Cardiol; 2007 Jul; 23(9):707-10. PubMed ID: 17622392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Emergent cardiovascular risk factor: homocysteine.
    Warren CJ
    Prog Cardiovasc Nurs; 2002; 17(1):35-41. PubMed ID: 11872979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Risk factors for cardiovascular diseases: what is the role for homocysteine?].
    Bendini MG; Lanza GA; Mazza A; Giordano A; Leggio M; Menichini G; De Cristofaro R; Moriconi E; Cozzari L; Farina SM; Giordano G
    G Ital Cardiol (Rome); 2007 Mar; 8(3):148-60. PubMed ID: 17461357
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical use and rational management of homocysteine, folic acid, and B vitamins in cardiovascular and thrombotic diseases.
    Stanger O; Herrmann W; Pietrzik K; Fowler B; Geisel J; Dierkes J; Weger M
    Z Kardiol; 2004 Jun; 93(6):439-53. PubMed ID: 15252738
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Homocysteine and cardiovascular disease: a review of the evidence.
    Wierzbicki AS
    Diab Vasc Dis Res; 2007 Jun; 4(2):143-50. PubMed ID: 17654449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of Combined Treatment With Folic Acid, Vitamin B
    Christen WG; Cook NR; Van Denburgh M; Zaharris E; Albert CM; Manson JE
    J Am Heart Assoc; 2018 May; 7(11):. PubMed ID: 29776960
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vitamins and minerals 4: overview of folate and the B vitamins.
    Thompson J
    Community Pract; 2006 Jun; 79(6):197-8. PubMed ID: 16780289
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Homocysteine, B vitamins, and cardiovascular disease.
    de Craen AJ; Stott DJ; Westendorp RG
    N Engl J Med; 2006 Jul; 355(2):205-6; author reply 209-11. PubMed ID: 16837687
    [No Abstract]   [Full Text] [Related]  

  • 12. Vitamin supplements and cardiovascular risk: review of the randomized trials of homocysteine-lowering vitamin supplements.
    Clarke R; Armitage J
    Semin Thromb Hemost; 2000; 26(3):341-8. PubMed ID: 11011852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The importance of folate, vitamins B6 and B12 for the lowering of homocysteine concentrations for patients with recurrent pregnancy loss and MTHFR mutations.
    Serapinas D; Boreikaite E; Bartkeviciute A; Bandzeviciene R; Silkunas M; Bartkeviciene D
    Reprod Toxicol; 2017 Sep; 72():159-163. PubMed ID: 28689805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Disturbances of homocysteine metabolism as a risk factor of cardiovascular diseases development: effect on prognosis and possibilities of correction with drugs].
    Shakhmatova OO; Komarov AL; Panchenko EP
    Kardiologiia; 2010; 50(1):42-50. PubMed ID: 20144157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The C677T MTHFR genotypes influence the efficacy of B9 and B12 vitamins supplementation to lowering plasma total homocysteine in hemodialysis.
    Achour O; Elmtaoua S; Zellama D; Omezzine A; Moussa A; Rejeb J; Boumaiza I; Bouacida L; Rejeb NB; Achour A; Bouslama A
    J Nephrol; 2016 Oct; 29(5):691-8. PubMed ID: 26559681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyperhomocysteinemia and cardiovascular risk: effect of vitamin supplementation in risk reduction.
    Ciaccio M; Bellia C
    Curr Clin Pharmacol; 2010 Feb; 5(1):30-6. PubMed ID: 20236081
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vitamins, homocysteine and cardiovascular risk.
    Graham IM; O'Callaghan P
    Cardiovasc Drugs Ther; 2002 Sep; 16(5):383-9. PubMed ID: 12652107
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of vitamin B12 and folic acid supplementation on biomarkers of endothelial function and inflammation among elderly individuals with hyperhomocysteinemia.
    van Dijk SC; Enneman AW; Swart KM; van Wijngaarden JP; Ham AC; de Jonge R; Blom HJ; Feskens EJ; Geleijnse JM; van Schoor NM; Dhonukshe-Rutten RA; de Jongh RT; Lips P; de Groot LC; Uitterlinden AG; van den Meiracker TH; Mattace-Raso FU; van der Velde N; Smulders YM
    Vasc Med; 2016 Apr; 21(2):91-8. PubMed ID: 26774115
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Total homocysteine concentration and associated cardiovascular and renal implications in adults.
    Bergen C; Compher C
    J Cardiovasc Nurs; 2006; 21(1):40-6. PubMed ID: 16407736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Homocysteine levels in patients treated with lipid apheresis: effect of a vitamin therapy.
    Julius U; Pietzsch J; Gromeier S; Schorr H; Herrmann W
    Eur J Clin Invest; 2001 Aug; 31(8):667-71. PubMed ID: 11473567
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.